Related Experiment Videos
Effect of naltrexone upon self-injurious behavior, learning and activity: a case study
D V Taylor1, W P Hetrick, C L Neri
1Department of Psychiatry and Human Behavior, University of California, Irvine.
Pharmacology, Biochemistry, and Behavior
|September 1, 1991
Summary
Naltrexone treatment reduced self-injurious behavior (SIB) in an autistic male patient. The medication also improved learning and memory without affecting activity levels.
Area of Science:
- Neuropharmacology
- Autism Spectrum Disorder Research
- Behavioral Science
Background:
- Self-injurious behavior (SIB) is a significant challenge in individuals with autism spectrum disorder (ASD).
- Pharmacological interventions are explored to manage challenging behaviors in ASD.
- Naltrexone, an opioid antagonist, has shown potential in modulating behavior.
Observation:
- A 20-year-old male patient with mild intellectual disability and autism exhibited significant SIB.
- Daily video recordings and computerized time-sampling assessed SIB frequency, severity, and activity levels.
- Paired associate learning tests (PALT) evaluated cognitive functions weekly.
Findings:
- Naltrexone administration led to a significant reduction in SIB frequency and severity.
- Improvements in learning and memory were observed during naltrexone treatment.
- Patient's overall activity levels remained unaffected by the medication.
Implications:
- Naltrexone may be a viable therapeutic option for reducing SIB in some individuals with autism.
- The findings suggest a potential role for naltrexone in enhancing cognitive functions in this population.
- Further research is warranted to explore naltrexone's efficacy and safety across diverse ASD presentations.